Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

4.03
Delayed Data
As of Apr 21
 -0.16 / -3.82%
Today’s Change
1.51
Today|||52-Week Range
9.45
+97.55%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close4.19
Today’s open4.17
Day’s range3.81 - 4.19
Volume4,177,110
Average volume (3 months)2,211,825
Market cap$352.0M
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)-135.21%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-29.86%
P/E ratioNM
Price/Sales4.46
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RXDXIgnyta Inc-0.10-1.17%
RIGLRigel Pharmaceutical...-0.16-5.28%
SYRSSyros Pharmaceutical...-0.64-4.12%
BTXBioTime Inc-0.04-1.26%
Data as of 4:00pm ET, 04/21/2017

Financials

Next reporting dateMay 31, 2017
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$60.0M
Annual profit (last year)-$144.8M
Net profit margin-241.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs